Table 4.
Age group (yr) | Females |
Males |
Total |
|||
---|---|---|---|---|---|---|
N | Rate (95% CI)a | n | Rate (95% CI)a | n | Rate (95% CI)a | |
Definite or likely ADPLD | ||||||
0–17 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
18–29 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
30–39 | 0 | 0.00 | 1 | 10.48 (0.27; 58.38) | 1 | 5.10 (0.13; 28.43) |
40–49 | 1 | 9.91 (0.25; 55.20) | 1 | 10.68 (0.27; 59.52) | 2 | 10.28 (1.24; 37.14) |
50–59 | 3 | 29.67 (6.12; 86.72) | 1 | 10.84 (0.27; 60.42) | 4 | 20.69 (5.64; 52.98) |
60–69 | 1 | 15.83 (0.40; 88.17) | 2 | 35.57 (4.31; 128.51) | 3 | 25.12 (5.18; 73.42) |
70–110 | 1 | 13.71 (0.35; 76.37) | 1 | 18.74 (0.47; 104.44) | 2 | 15.83 (1.92; 57.20) |
All ages | 6 | 8.93 (1.77; 16.09) | 6 | 10.23 (41.96; 18.51) | 12 | 9.52 (4.11; 14.94) |
Definite, likely or possible ADPLD | ||||||
0–17 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
18–29 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
30–39 | 0 | 0.00 | 1 | 10.48 (0.27; 58.38) | 1 | 5.10 (0.13; 28.43) |
40–49 | 1 | 9.91 (0.25; 55.20) | 2 | 21.37 (2.59; 77.18) | 3 | 15.42 (3.18; 45.06) |
50–59 | 9 | 89.02 (40.71; 168.99) | 4 | 43.37 (11.82; 111.06) | 13 | 67.25 (35.81; 114.99) |
60–69 | 6 | 94.95 (34.85; 206.67) | 4 | 71.15 (19.39; 182.17) | 10 | 83.75 (40.16; 154.01) |
70–110 | 10 | 137.06 (65.73; 252.06) | 7 | 131.21 (52.75; 270.34) | 17 | 134.59 (78.40; 215.49) |
All ages | 26 | 39.26 (24.13; 54.39) | 18 | 32.33 (17.28; 47.39) | 44 | 35.96 (25.30; 46.61) |
ADPLD, autosomal-dominant polycystic liver disease.
Rates for females and males are adjusted for age, whereas the total rate is adjusted for age and sex.